Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 001-41153

ALPHA STAR ACQUISITION CORPORATION

(Exact name of registrant as specified in its charter)

Cayman Islands		N/A
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

80 Broad Street, 5^thFloorNew York, New York 10004

(Address of Principal Executive Offices, including zip code)

(212) 837-7977

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one ordinary share, one redeemable warrant, and one right	ALSAU	The Nasdaq Stock Market LLC
Ordinary Shares, $0.001 par value	ALSA	The Nasdaq Stock Market LLC
Redeemable warrants entitle the holder to purchase one-half (1/2) of one ordinary share	ALSAW	The Nasdaq Stock Market LLC
Rights entitle the holders to receive one-seventh (1/7) of one Ordinary Share	ALSAR	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐	Large accelerated filer	☐	Accelerated filer
☒	Non-accelerated filer	☒	Smaller reporting company
		☒	Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

Indicate the number of shares outstanding of each of the registrant’s classes of ordinary shares, as of the latest practicable date: As of July 12, 2024 there were 8,948,580 ordinary shares, respectively, with par value of $0.001, issued and outstanding (assuming all of the units issued in our initial public offering completed on December 15, 2021 were split on such date).

ALPHA STAR ACQUISITION CORPORATION

FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2024

TABLE OF CONTENTS

			Page
Part I. Financial Information
	Item 1.	Financial Statements	1
		Balance Sheets (Unaudited)	1
		Statements of Operations (Unaudited)	2
		Statements of Changes in Stockholders’ Deficit (Unaudited)	3
		Statements of Cash Flows (Unaudited)	4
		Notes to Unaudited Financial Statements	5
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16
	Item 3.	Quantitative and Qualitative Disclosures Regarding Market Risk	20
	Item 4.	Controls and Procedures	20

Part II. Other Information
	Item 1.	Legal Proceedings	21
	Item 1A.	Risk Factors	21
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	21
	Item 3.	Defaults Upon Senior Securities	22
	Item 4.	Mine Safety Disclosures	22
	Item 5.	Other Information	22
	Item 6.	Exhibits	22

Part III. Signatures			23

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

ALPHA STAR ACQUISITION CORPORATION

BALANCE SHEETS

(Unaudited)

	March 31,			December 31,
	2024			2023
Assets
Current assets:
Prepaid expense	$	66,375		$	12,500
Total current assets		66,375			12,500
Noncurrent assets:
Marketable securities held in trust account		65,650,502			101,590,662
Total noncurrent assets		65,650,502			101,590,662
Total assets	$	65,716,877		$	101,603,162

Liabilities and stockholders’ deficit
Current liabilities:
Accrued expenses	$	323,728		$	220,401
Promissory note – Sponsor		6,035,961			5,755,961
Due to related parties		402,141			212,660
Total current liabilities		6,761,830			6,189,022
Noncurrent liabilities:
Deferred underwriting commissions		2,875,000			2,875,000
Total noncurrent liabilities		2,875,000			2,875,000
Total liabilities		9,636,830			9,064,022

Commitment and contingencies (Note 6)		-			-
Ordinary shares subject to possible redemption, 5,743,580 and 9,063,503 shares at redemption value of $11.42 and $11.21 per share at March 31, 2024 and December 31, 2023, respectively		65,595,501			101,605,662

Stockholders’ deficit:
Ordinary shares, par value $0.001, authorized 50,000,000 shares; 3,205,000 and 3,205,000 shares issued and outstanding at March 31 2024 and December 31, 2023, respectively, excluding 5,743,580 and 9,063,503 shares subject to possible redemption		3,205			3,205
Additional paid-in capital		-			-
Accumulated deficit		(9,518,659	)		(9,069,727	)

Total stockholders’ deficit		(9,515,454	)		(9,066,522	)

Total liabilities and stockholders’ deficit	$	65,716,877		$	101,603,162

The accompanying notes are an integral part of the unaudited financial statements.

ALPHA STAR ACQUISITION CORPORATION

STATEMENTS OF OPERATIONS
(Unaudited)

	For the Three Months Ended March 31, 2024			For the Three Months Ended March 31, 2023
Formation and operational costs	$	238,932		$	121,309
Loss from operations		(238,932	)		(121,309	)

Other income:
Interest realized on marketable securities held in Trust Account		677,001			807,326
Unrealized gain on marketable securities held in Trust Account		285,976			461,067
Total other income		962,977			1,268,393

Income before income taxes		724,045			1,147,084

Income tax expense		-			-
Net income	$	724,045		$	1,147,084

Basic and diluted weighted average shares outstanding - ordinary shares subject to redemption		6,108,407			11,500,000
Basic and diluted net income per share	$	0.14		$	0.12

Basic and diluted weighted average shares outstanding – Non-redeemable ordinary shares		3,205,000			3,205,000
Basic and diluted net loss per share	$	(0.05	)	$	(0.09	)

The accompanying notes are an integral part of the unaudited financial statements.

ALPHA STAR ACQUISITION CORPORATION

STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(Unaudited)

For the three months ended March 31, 2024 and 2023

	Shares		Amount		Capital		Deficit			Deficit
	Ordinary Shares				Additional Paid-In		Accumulated			Total Stockholders’
	Shares		Amount		Capital		Deficit			Deficit
Balance at December 31, 2023		3,205,000	$	3,205	$	-	$	(9,069,727	)	$	(9,066,522	)
Subsequent measurement of ordinary shares subject to possible redemption (interest earned and unrealized gain on trust account)		-		-		-		(962,977	)		(962,977	)
Subsequent measurement of ordinary shares subject to possible redemption (additional funding for business combination extension)		-		-		-		(210,000	)		(210,000	)
Net income		-		-		-		724,045			724,045
Balance at March 31, 2024		3,205,000	$	3,205	$	-	$	(9,518,659	)	$	(9,515,454	)

	Ordinary Shares				Additional Paid-In		Accumulated			Total Stockholders’
	Shares		Amount		Capital		Deficit			Deficit
Balance at December 31, 2022		3,205,000	$	3,205	$	-	$	(4,522,095	)	$	(4,518,890	)
Balance		3,205,000	$	3,205	$	-	$	(4,522,095	)	$	(4,518,890	)
Subsequent measurement of ordinary shares subject to possible redemption (interest earned and unrealized gain on trust account)		-		-		-		(1,268,393	)		(1,268,393	)
Subsequent measurement of ordinary shares subject to possible redemption (additional funding for business combination extension)		-		-		-		(1,149,999	)		(1,149,999	)
Net income		-		-		-		1,147,084			1,147,084
Balance at March 31, 2023		3,205,000	$	3,205	$	-	$	(5,793,403	)	$	(5,790,198	)
Balance		3,205,000	$	3,205	$	-	$	(5,793,403	)	$	(5,790,198	)

The accompanying notes are an integral part of the unaudited financial statements.

ALPHA STAR ACQUISITION CORPORATION

STATEMENTS OF CASH FLOWS

(Unaudited)

	For the Three Months Ended March 31, 2024			For the Three Months Ended March 31, 2023
Cash flows from operating activities:
Net loss	$	724,045		$	1,147,084

Net changes in operating assets & liabilities:
Prepaid expenses		(53,875	)		(52,500	)
Interest earned in Trust Account		(962,977	)		(1,268,393	)
Due to related parties		189,481			140,977
Accrued expenses		103,326			(58,965	)
Net cash used in operating activities		-			(91,797	)

Cash flows from investing activities:
Investment of cash in Trust Account		(280,000	)		(1,149,999	)
Cash withdrawn from Trust Account to redeem public shares		37,183,138			-
Cash withdrawn from Trust Account for account service fee		-			7,500
Net cash provided by (used in) investing activities		36,903,138			(1,142,499	)

Cash flows from financing activities:
Proceeds from Sponsor loan		280,000			1,149,999
Redemption of Public Shares		(37,183,138	)		-
Net cash (used in) provided by financing activities		(36,903,138	)		1,149,999

Net decrease in cash in escrow		-			(84,297	)
Cash in escrow at beginning of period		-			110,991
Cash in escrow at end of period	$	-		$	26,694

Supplemental disclosure of non-cash investing and financing activities:
Subsequent measurement of ordinary shares subject to possible redemption	$	1,172,977		$	2,418,392

The accompanying notes are an integral part of the unaudited financial statements.

ALPHA STAR ACQUISITION CORPORATION

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS

Note 1 – Description of Organization and Business Operations

Organization and General

Alpha Star Acquisition Corporation (the “Company”) is a blank check company incorporated in the Cayman Islands on March 11, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). The Company has selected December 31 as its fiscal year end.

Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses that have a connection to the Asian market. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

The Company’s sponsor is A-Star Management Corporation, a British Virgin Islands incorporated company (the “Sponsor”). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering (the “IPO”).

The Company initially had 9 months from the closing of the IPO (or up to 21 months from the closing of IPO) to consummate a Business Combination (the “Combination Period”). If the Company fails to consummate a Business Combination within the Combination Period, it will trigger its automatic winding up, liquidation and subsequent dissolution pursuant to the terms of the Company’s amended and restated memorandum and articles of association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Law. Accordingly, no vote would be required from the Company’s shareholders to commence such a voluntary winding up, liquidation and subsequent dissolution.

The Company’s IPO was declared effective on December 13, 2021. On December 15, 2021, the Company consummated the IPO of 11,500,000 units which include an additional 1,500,000 units as a result of the underwriters’ full exercise of the over-allotment, at $10.00 per Unit, generating gross proceeds of $115,000,000, which is described in Note 3.

Concurrently with the closing of the IPO, the Company consummated the sale of 330,000 units (the “Private Placement”) at a price of $10.00 per Private Unit in a private placement to the Sponsor, generating gross proceeds of $3,300,000, which is described in Note 4.

In connection with the stockholders’ extension vote at the Annual General Meeting held on July 13, 2023, 2,436,497 public shares were rendered for redemption. The total redemption payment was $26,094,883 and all distributed during July and August 2023.

Extraordinary General Meeting

On January 10, 2024, the Company held an Extraordinary General Meeting, where shareholders approved the amendments of the Company’s Amended and Restated Memorandum and Articles of Association to (i) extend the date by which the Company must consummate a business combination to September 15, 2024 (33 months from the consummation of the IPO) (the “Combination Period”); (ii) allow the Company to undertake an initial business combination with an entity or business (“Target Business”), with a physical presence, operation, or other significant ties to China (a “China-based Target”) or which may subject the post-business combination business or entity to the laws, regulations and policies of China (including Hong Kong and Macao), or an entity or business that conducts operations in China through variable interest entities, or VIEs, pursuant to a series of contractual arrangements (“VIE Agreements”) with the VIE and its shareholders on one side, and a China-based subsidiary of the China-based Target (the “WFOE”), on the other side (the “Target Limitation Amendment Proposal”); and (iii) eliminate the limitation that the Company shall not redeem its public shares to the extent that such redemption would result in the ordinary shares, or the securities of any entity that succeeds the Company as a public company, becoming “penny stock” (as defined in accordance with Rule 3a51-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), or cause the Company to not meet any greater net tangible asset or cash requirement which may be contained in the agreement relating to a Business Combination (the “Redemption Limitation Amendment Proposal”).

In connection with the stockholders’ extension vote on the Extraordinary General Meeting held on January 10, 2024, a total of 3,319,923 public shares were rendered for redemption. The total redemption payment was $37,183,138 and all distributed in January and February 2024.

Extension fees

From September 13, 2022 to June 30, 2023, the Company was requested to draw the funds of $383,333 and deposited the amount into the Trust Account monthly to extend the period of time the Company has to consummate a business combination. The $383,333 extension fee represents approximately $0.033 per public share. The extension funds will decrease if certain shareholders redeem the shares. In July 2023, due to the Annual General Meeting discussed above and the redemption of public shares, the monthly extension fees were changed to $302,116, which represents $0.033 per public share. In January 2024, after shareholders’ approval at the Extraordinary General Meeting discussed above, the Company decreased the monthly extension fees to the lower of $70,000 for all remaining public shares and $0.033 for each remaining public shares.

The Trust Account

As of December 15, 2021, a total of $115,682,250 of the net proceeds from the IPO and the Private Placement transaction completed with the Sponsor was deposited in a trust account (the “Trust Account”) established for the benefit of the Company’s public stockholders with Wilmington Trust, National Association acting as trustee. The amount exceeding $115,000,000, $682,250, had been transferred to the Company’s escrow cash account as its working capital.

The funds held in the Trust Account are invested only in United States government treasury bills, bonds or notes having a maturity of 180 days or less, or in money market funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company Act of 1940 and investing solely in United States government treasuries. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its income or other tax obligations, the proceeds will not be released from the Trust Account until the earlier of the completion of a Business Combination or the Company’s liquidation.

Liquidity and Going Concern

As of March 31, 2024 and December 31, 2023, the Company had no cash balance in the escrow account and had a working capital deficit of $6,710,455 and $6,191,522, including the over-withdraw of $15,000 from Marketable Security held in trust.

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company related party loans up to $1,500,000. As of March 31, 2024. The Company had no borrowings under the related party loans.

On September 13, 2022, December 31, 2022, March 13, 2023 and September 20, 2023, the Company issued four promissory notes (collectively, the “Notes”) in the principal amount of up to $1,000,000, $1,300,000, $2,500,000 and $2,500,000 to the Sponsor, respectively, pursuant to which the Sponsor shall loan to the Company up to the corresponding principal to pay the extension fee and transaction cost. See Note 5 for further information.

If the Company underestimates the costs of identifying a target business, undertaking due diligence and negotiating a Business Combination or the actual amount necessary is higher, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. Moreover, the Company may need to obtain additional financing either to complete its Business Combination or because the Company has become obligated to redeem a significant number of its Public Shares upon completion of its Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Business Combination. In addition, the Company has until December 15, 2024 (the “Liquidation Date”) to consummate a business combination.

In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Codification (“ASC”) 205-40, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to complete a Business Combination by the Liquidation Date, then the Company may cease all operations except for the purpose of liquidating. The uncertainty surrounding the date for mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Management believes that, as of March 31, 2024, the Company has insufficient working capital to cover its short term operating needs. The Company has no revenue before the Business Combination. It incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination. The Company’s cash and working capital as of March 31, 2024 are not sufficient to complete its planned activities for the upcoming year. These factors raise substantial doubt about the Company’s ability to continue as a going concern one year from the date the financial statement is issued.

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying financial statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”).

The accompanying unaudited financial statements as of March 31, 2024, and for the three months ended March 31, 2024 have been prepared in accordance with U.S. GAAP for interim financial information and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months ended March 31, 2024 are not necessary indicative of the results that may be expected for the period ending December 31, 2024, or any future period.

These unaudited financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto included in the Annual Report for the year ended December 31, 2023, which are included in Form 10-K filed on July 3, 2024.

Emerging Growth Company

The Company is an emerging growth company as defined by Section 2(a) of the JOBS Act and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but no limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosures obligations regarding executive compensation in its periodic reports and proxy statements, and exceptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payment not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with those of another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events.

Cash in Escrow

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash held in escrow and did not have any cash equivalents as of March 31, 2024 and December 31, 2023, respectively.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which at times may exceed the Federal depository insurance coverage of $250,000. As of March 31, 2024 and December 31, 2023, the Company does not have a cash account in any financial institutions, respectively.

Marketable Securities Held in Trust Account

The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned and unrealized gain on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. The Company had $65,650,502 and $101,590,662 of marketable securities held in the Trust Account as of March 31, 2024 and December 31, 2023.

In January and February, 2024, the total amounts of $37,183,138 was withdrawn from the Trust account for the redemption of 3,319,923 public shares.

During the three months ended March 31, 2024 and 2023, interest earned from the Trust Account amounted to $962,977 and $1,268,393, of which $677,001 and $807,326 were reinvested in the Trust Account, respectively, $285,976 and $461,067 were also recognized as unrealized gain on investments held in the Trust Account during the three months ended March 31, 2024 and 2023, respectively.

Ordinary Shares Subject to Possible Redemption

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as stockholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets.

Offering Costs Associated with the Initial Public Offering

The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offering”. Offering costs consisted of principally of professional and registration fees incurred that were directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to the Rights were charged to the shareholders’ equity. Offering costs allocated to the ordinary shares were charged against the carrying value of ordinary shares subject to possible redemption upon the completion of the Initial Public Offering.

All of the 11,500,000 ordinary shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s Certificate of Incorporation. Accordingly, all of the 11,500,000 shares of ordinary shares were presented as temporary equity upon closing of the IPO.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in capital and accumulated deficit if additional paid in capital equals to zero. The interest earned by the marketable security held in trust, and the extension fee invested into the marketable security held in trust, were also recognized in redemption value against additional paid-in capital and accumulated deficit immediately. The proceeds on the deposit in the Trust Account, including interest (which interest shall be net of taxes payable, and less up to $50,000 of interest to pay dissolution expenses) will be used to fund the redemption of the public shares.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheets, primarily due to the short-term nature.

Net Income (Loss) per Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public stockholders.

The calculation of diluted income (loss) per ordinary shares does not consider the effect of the warrants and rights issued in connection with the (i) Initial Public Offering, (ii) the private placement since the exercise of the warrants and rights are contingent upon the occurrence of future events, and (iii) the effect of the rights to receive 1,690,000 shares. The warrants are exercisable to purchase 5,915,000 shares of ordinary shares in the aggregate. As of March 31, 2024, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares in the earnings of the Company. As a result, diluted net income (loss) per ordinary shares is the same as basic net income (loss) per ordinary share for the periods presented.

The net income (loss) per share presented in the statements of operations is based on the following:

Schedule of Statement of Operations

	For the Three Months Ended March 31, 2024			For the Three Months Ended March 31, 2023
Net income	$	724,045		$	1,147,084
Remeasurement to redemption value – interest income earned		(962,977	)		(1,268,393	)
Remeasurement to redemption value – extension fee		(210,000	)		(1,149,999	)
Net loss including accretion of temporary equity to redemption value	$	(448,932	)	$	(1,271,308	)

Schedule of Net Income (Loss) Per Share


	For the Three Months Ended March 31, 2024						For the Three Months Ended March 31, 2023
	Non-redeemable shares			Redeemable shares			Non-redeemable shares			Redeemable shares
Basic and Diluted net income (loss) per share:
Numerators:
Allocation of net losses	$	(154,490	)	$	(294,442	)	$	(277,085	)	$	(994,223	)
Accretion of extension fee		-			210,000			-			1,149,999
Accretion of temporary equity - interest income earned		-			962,977			-			1,268,393
Allocation of net income (loss)	$	(154,490	)	$	878,535		$	(277,085	)	$	1,424,169

Denominators:
Weighted-average shares outstanding		3,205,000			6,108,407			3,205,000			11,500,000
Basic and diluted net income (loss) per share	$	(0.05	)	$	0.14		$	(0.09	)	$	0.12

Income Taxes

The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company has identified the Cayman Islands as its only “major” tax jurisdiction, as defined. Any interest payable in respect of U.S. debt obligations (if any) held by the Trust Account is intended to qualify for the portfolio interest exemption or otherwise be exempt from U.S. withholding taxes. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial position. The Company’s policy for recording interest and penalties associated with audits is to record such items as a component of income tax expense.

On August 16, 2022, the U.S. Government enacted legislation commonly referred to as the Inflation Reduction Act. The main provision of the Inflation Reduction Act (the IRA) that we anticipate may impact us is a 1% excise tax on share repurchases. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Because there is possibility that the Company may acquire a U.S. domestic corporation or engage in a transaction in which a domestic corporation becomes a parent or affiliate to the Company, the Company may become a “covered corporation” as a listed Company in Nasdaq. On July 13, 2023 and January 10, 2024, 2,436,497 and 3,319,923 public shares were rendered for redemption in connection with an extension vote, respectively (see Note 1). The management team has evaluated the IRA as of March 31, 2024, and does not accrue any excise tax related to the redemption as the Company believes it is not a “covered corporation” under Internal Revenue Code Section 4501. The management team will continue to evaluate its impact.

The provision for income taxes was deemed to be immaterial for the three months ended March 31, 2024 and for the three months ended March 31, 2023.

Warrants

The Company evaluates the Public and Private Warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480 that meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such an evaluation, both Public and Private Warrants are classified in stockholders’ equity.

Recently Issued Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Note 3 – Initial Public Offering

On December 15, 2021, the Company consummated the initial public offering and sale of 11,500,000 units (including the issuance of 1,500,000 units as a result of the underwriters’ full exercise of the over-allotment) at a price of $10.00 per Unit, generating gross proceeds of $115,000,000. Each Unit consists of one ordinary share, one redeemable warrant (each a “Warrant”, and, collectively, the “Warrants”), and one right to receive one-seventh (1/7) of an ordinary share upon the consummation of a Business Combination. Each two redeemable warrants entitle the holder thereof to purchase one ordinary share, and each seven rights entitle the holder thereof to receive one ordinary share at the closing of a Business Combination. No fractional shares were issued upon separation of the Units, and only whole Warrants will trade.

Note 4 – Private Placement

Concurrently with the consummation of the IPO, A-Star Management Corporation, the Sponsor, purchased an aggregate of 330,000 units at a price of $10.00 per Private Unit for an aggregate purchase price of $3,300,000 in a private placement. The Private Units are identical to the public Units except with respect to certain registration rights and transfer restrictions. The proceeds from the Private Units were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Units and all underlying securities will expire worthless.

Note 5 – Related Party Transactions

Founder Shares

On April 6, 2021, the Sponsor purchased 2,875,000 ordinary shares for an aggregate price of $25,000.

The 2,875,000 founder shares (for purposes hereof referred to as the “Founder Shares”) included an aggregate of up to 375,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the Sponsor will collectively own 20% of the Company’s issued and outstanding shares after the Proposed Offering. On December 15, 2021, the underwriters exercised the over-allotment option in full, so there are no Founder Shares subject to forfeiture as of March 31, 2024 and December 31, 2023.

The Sponsor and each Insider agrees that it, he or she shall not (a) Transfer 50% of their Founder Shares until the earlier of (A) six months after the consummation of the Company’s initial Business Combination or (B) the date on which the closing price of the Ordinary Shares equals or exceeds $12.50 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s initial Business Combination or (b) Transfer the remaining 50% of their Founder Shares until six months after the date of the consummation of the Company’s initial Business Combination, or earlier in either case, if subsequent to the Company’s initial Business Combination the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their Ordinary Shares for cash, securities or other property (the “Founder Shares Lock-up Period”).

Administrative Services Agreement

The Company entered into an administrative services agreement, commencing on December 13, 2021, through the earlier of the Company’s consummation of a Business Combination or its liquidation, to pay to the Sponsor a total of $10,000 per month for office space, secretarial and administrative services provided to members of the Company’s management team. For each of the three months ended March 31, 2024 and 2023, the Company incurred $30,000 and $30,000 in fees for these services, respectively, which were included in the “Accrued expenses” on the balance sheets of the Company.

Promissory Note — Sponsor

In order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units at a price of $10.00 per unit (which, for example, would result in the holders being issued 150,000 ordinary shares, 150,000 rights and 150,000 warrants to purchase 75,000 shares if $1,500,000 of notes were so converted) at the option of the lender. The units would be identical to the placement units issued to the initial holder. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. The convertible loans from Sponsor balances were nil as of March 31, 2024 and December 31, 2023.

The Company had issued the following promissory notes (collectively, the “Notes”):

On September 13, 2022, December 13, 2022. March 13, 2023 and September 20, 2023 the Company issued four promissory notes in the principal amount of up to $1,000,000, $1,300,000, $2,500,000 and $2,500,000, respectively, to the Sponsor, pursuant to which the Sponsor shall loan to the Company up to the related amount to pay the extension fee and transaction cost. The Notes are repayable in full upon the date of the consummation of the Company’s initial business combination pursuant to the Notes. The Notes have no conversion feature, no collateral and bear no interest.

The total balance of the Notes was $6,035,961 and $5,755,961 as of March 31, 2024 and December 31, 2023, respectively, which was for the purpose of paying extension contribution.

Due to related parties

On March 31, 2024 and December 31, 2023, the Company has amount due to Sponsor of $402,141 and $212,660, respectively, which included the amount of operating expenses paid by the Sponsor on behalf of the Company and the reimbursement of the operating expenses paid by a director of the Company.

Note 6 – Commitments and Contingencies

Risks and Uncertainties

In February 2022, the Russian Federation and Belarus commenced a military action against the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these unaudited condensed consolidated financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed consolidated financial statements. The management will continuously evaluate the effect of these events on the Company.

Underwriters Agreement

The Company granted the underwriters a 45-day option to purchase up to 1,500,000 Units (over and above the 10,000,000 units referred to above) solely to cover over-allotments at $10.00 per Unit. On December 15, 2021, the underwriters exercised the over-allotment option in full to purchase 1,500,000 Units at a purchase price of $10.00 per Unit.

On December 15, 2021, the Company paid a cash underwriting commission of 2.0% of the gross proceeds of the IPO, or $2,300,000.

The underwriters are entitled to a deferred underwriting commission of 2.5% of the gross proceeds of the IPO, or $2,875,000, which will be paid from the funds held in the Trust Account upon completion of the Company’s initial Business Combination subject to the terms of the underwriting agreement. The Company has deferred underwriting commissions of $2,875,000 and $2,875,000 as of March 31, 2024 and December 31, 2023, respectively.

Registration Rights

The holders of the Founder Shares will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the IPO. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Contingencies and Dismissal of the Then-Legal Counsel

The Company may from time to time be subject to various legal or administrative claims and proceedings arising in the ordinary course of business. As of March 31, 2024 and December 31, 2023, there were no legal or administrative proceedings for which a loss was probable and expected to be material to the financial statements.

On February 5, 2024, the management and the Sponsor determined to dismiss the Company’s then-legal counsel and also terminated its services of maintaining and managing the escrow account. The former legal counsel alleged that there was an approximately $200,000 balance due with the Sponsor and disputed legal fee due with the Company. On May 23, 2024, the Sponsor and the Company entered into an indemnity agreement that contractually indemnifies, holds harmless, and exonerates the Company from any potential litigation or related proceedings arising from the service termination with the former legal counsel. The Company does not believe that either the above Sponsor Balance due with the former legal counsel or the disputed legal fee would have a material impact on the Company’s financial statements.

Note 7 – Stockholders’ Deficit

Ordinary Shares

The Company is authorized to issue 50,000,000 ordinary shares, with a par value of $0.001 per share. Holders of the ordinary shares are entitled to one vote for each ordinary share. At March 31, 2024 and December 31, 2023, there were 3,205,000 ordinary shares issued and outstanding, excluding 5,743,580 and 9,063,503 shares subject to possible redemption.

Public Warrants

Pursuant to the Initial Public Offering, the Company sold 11,500,000 Units at a price of $10.00 per Unit for a total of $115,000,000. The total amount of ordinary shares subject to possible redemption is 11,500,000. Each Unit consists of one ordinary share, one right to acquire one-seventh (1/7) of an ordinary share, and one redeemable warrant (“Public Warrant”) to purchase one-half of one ordinary share at a price of $11.50 per share, subject to adjustment. As of March 31, 2024 and December 31, 2023, the Company had 11,500,000 and 11,500,000 public warrants outstanding, respectively.

Each warrant entitles the holder to purchase one-half ordinary share at a price of $11.50 per share commencing 30 days after the completion of its initial business combination and expiring five years from after the completion of an initial business combination. No fractional warrant will be issued and only whole warrants will trade. The Company may redeem the warrants at a price of $0.01 per warrant upon 30 days’ notice, only in the event that the last sale price of the ordinary shares is at least $18.00 per share for any 20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given, provided there is an effective registration statement and current prospectus in effect with respect to the ordinary shares underlying such warrants during the 30-day redemption period. If a registration statement is not effective within 60 days following the consummation of a business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act.

In addition, if (a) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination, and (c) the volume weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value, and the last sales price of the ordinary shares that triggers the Company’s right to redeem the Warrants will be adjusted (to the nearest cent) to be equal to 180% of the Market Value.

Private warrants

The private warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering. As of March 31, 2024 and December 31, 2023, the Company had 330,000 private warrants outstanding, respectively.

Rights

Except in cases where the Company is not the surviving Company in a business combination, the holders of the rights will automatically receive 1/7 of a share of ordinary shares upon consummation of the Company’s initial business combination. In the event the Company will not be the surviving company upon completion of the initial business combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the 1/7 of a share underlying each right upon consummation of the business combination. As of March 31, 2024 and December 31, 2023, no rights had been converted into shares.

Note 8 – Fair Value Measurements

The Company complies with ASC 820, “Fair Value Measurements”, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. ASC 820 determines fair value to be the price that would be received to sell an asset or would be paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date.

The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2: Observable inputs other than Level inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

At March 31, 2024 and December 31, 2023, assets held in the Trust Account were entirely comprised of marketable securities.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

As of March 31, 2024		Quoted Prices in Active Markets (Level 1)				Significant Other Observable Inputs (Level 2)				Significant Other Unobservable Inputs (Level 3)
Marketable Securities held in Trust Account		$	65,650,502			$	-			$	-

As of December 31, 2023		Quoted Prices in Active Markets (Level 1)				Significant Other Observable Inputs (Level 2)				Significant Other Unobservable Inputs (Level 3)
Marketable Securities held in Trust Account		$	101,590,662			$	-			$	-

Note 9 – Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date the financial statements were issued. Based upon the review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statement except those have been disclosed elsewhere in the Note to the financial statements and the following:

Sponsor payment on behalf of the Company

Subsequent to March 31, 2024, in addition to the monthly admin service fee charged by the Sponsor which is recorded under the “Accrued expenses”, the Sponsor paid a total of $250,713 operating expenses on behalf of the Company. The payment by the Sponsor was not considered as a drawdown of the Promissory Note. As of the date the financial statements were issued, the total amount due to Sponsor was $652,854.

Enter into Letter of Intent

On June 24, 2024, the Company issued a press release announcing its entry into a non-binding Letter of Intent for a business combination with XDATA GROUP OÜ, an Estonia-based financial technology solutions company.

Annual General Meeting

On July 12, 2024, the Company held an Annual General Meeting of its shareholders. At the Annual General Meeting, the shareholders approved certain amendments to the Company’s amended and restated memorandum and articles of association to extend the date by which the Company must consummate a business combination to December 15, 2024. In connection with the stockholders’ extension vote on the Annual General Meeting held on July 12, 2024, a total of 4,840,581 public shares were rendered for redemption at $11.61 per share. After shareholders’ approval at the Annual General Meeting, the Company decreased the monthly extension fees to $35,000 for all remaining public shares, starting from July 2024.

Drawdown of Promissory Notes

Subsequent to March 31, 2024, the Company drew down $210,000 from the Promissory Notes to pay the extension contribution of $70,000 each month from May 2024 to June 2024, and $35,000 each month from July to August, respectively. The full amounts were deposited into the Trust Account immediately.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Alpha Star Acquisition Corporation. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to A-Star Management Corporation. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and variations thereof and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please consult the Company’s securities filings on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated in the Cayman Islands on March 11, 2021 formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Units, our shares, debt or a combination of cash, shares and debt.

We expect to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Results of Operations

We have neither engaged in any operations nor generated any operating revenues to date. Our only activities from inception through March 31, 2024 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenue until after the completion of our initial Business Combination. We expect to generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

For the three months ended March 31, 2024, we had a net income of $724,045, which consists of operating costs of $238,932, offset by interest income on marketable securities held in the Trust Account of $677,001 and unrealized interest income on marketable securities held in the Trust Account of $285,976.

For the three months ended March 31, 2023, we had a net income of $1,147,084, which consists of operating costs of $121,309, offset by interest income on marketable securities held in the Trust Account of $807,326 and unrealized interest income on marketable securities held in the Trust Account of $461,067.

Liquidity and Capital Resources

On December 15, 2021, the Company consummated the IPO of 11,500,000 units (including the exercise of the over-allotment option by the underwriters in the IPO) at $10.00 per unit (the “Public Units”), generating gross proceeds of $115,000,000. Each Unit consists of one ordinary share, one redeemable warrant to purchase one-half (1/2) ordinary share (each a “Warrant”, and, collectively, the “Warrants”), and one right to receive one-seventh (1/7) of an ordinary share upon the consummation of a Business Combination. Simultaneously with the IPO, the Company sold to its Sponsor 330,000 units at $10.00 per unit in a private placement generating total gross proceeds of $3,300,000. Offering costs amounted to $5,669,696 consisting of $2,300,000 of underwriting fees, $2,875,000 of deferred underwriting fees, and 494,696 of other offering costs. Apart from $25,000 for the subscription of ordinary shares, the Company received net proceeds of $115,682,250 from the IPO and the private placement.

For the three months ended March 31, 2024, there was no net cash used in operating activities. Net income of $724,045 consisted of formation and operating costs $238,932 and offset by interest earned on marketable securities held in trust of $677,001 and unrealized interest earned on marketable securities held in trust $285,976. Net cash used by financing activities was $36,903,138, consisting of $37,183,138 for the redemption of public shares offset by the proceed of sponsor promissory note $280,000. Net cash provided by investing activities was $36,903,138, consisting of $280,000 to invest the cash into the marketable security held in trust account and $37,183,138 cash withdrawn from trust account to redeem public shares.

For the three months ended March 31, 2023, net cash used in operating activities was $91,797. Net income of $1,147,084 consisted of formation and operating costs $121,309 and was offset by interest earned on marketable securities held in trust of $807,326 and unrealized interest earned on marketable securities held in trust $461,067. Net cash provided by financing activities was $1,149,999 extension contributions from the proceeds of sponsor promissory note, off set by a withdrawal from the Trust Account for the account service fee of $7,500. Net cash used by investing activities was $1,149,999 to invest the cash into the marketable security held in trust account.

At March 31, 2024, we had marketable securities held in the Trust Account of $65,650,502. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, excluding deferred underwriting commissions, to complete our Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

At March 31, 2024, we had cash in escrow of $0 held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

In order to complete a Business Combination, the Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern if a Business Combination is not consummated.

The Company had issued the following promissory notes (collectively, the “Notes”):

The issuance of the Notes was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. The total balance of the Notes was $6,035,961 and $5,755,961 as of March 31, 2024 and December 31, 2023, respectively.

We believe we will need to raise additional funds in order to meet the expenditures required for operating our business. If our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination is less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

Off-Balance Sheets Financing Arrangements

We have no obligations, assets or liabilities that would be considered off-balance sheets arrangements as of March 31, 2024. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheets arrangements. We have not entered into any off-balance sheets financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor a monthly fee of $10,000 for certain general and administrative services, including office space, utilities and administrative services, provided to the Company. We began incurring these fees on December 15, 2021 and will continue to incur these fees monthly until the earlier of the completion of a Business Combination and the Company’s liquidation.

The underwriters are entitled to a deferred fee of two and one-half percent (2.5%) of the gross proceeds of the Initial Public Offering, or $2,875,000. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.

Critical Accounting Policies

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Warrants

The Company evaluates the Public and Private Warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification(“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480 and meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both Public and Private Warrants are classified in stockholders’ equity.

Ordinary Shares Subject to Possible Redemption

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as stockholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.

Basic and diluted net income (loss) per share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) rateably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public stockholders.

The calculation of diluted net income (loss) per ordinary shares and related weighted average of the ordinary shares does not consider the effect of the warrants and rights issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants and rights are contingent upon the occurrence of future events. The warrants are exercisable to purchase 5,915,000 shares of ordinary shares in the aggregate, and the rights are exercisable to convert 1,690,000 shares of ordinary shares in the aggregate. As of March 31, 2024, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company other than above. As a result, diluted net income (loss) per ordinary shares is the same as basic net income (loss) per ordinary shares for the periods presented.

Recent accounting standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our interim condensed financial statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As of March 31, 2024, we were not subject to any market or interest rate risk. Following the consummation of our Initial Public Offering, the net proceeds of our Initial Public Offering, including amounts in the Trust Account, have been invested in certain U.S. government securities with a maturity of 180 days or less or in certain money market funds that invest solely in U.S. treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our chief executive officer and chief financial officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2024. Based upon their evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective as of March 31, 2024.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our chief executive officer and chief financial officer, to allow timely decisions regarding required disclosure.

We have identified a material weakness in our internal control over financial reporting as of December 31, 2023, relating to ineffective review and approval procedures over journal entries and financial statement preparation which resulted in errors not being timely identified in previously issued financial statements, such as the misclassification of the trust account balance and deferred underwriting commissions payable as current assets and current liabilities instead of non-current assets and non-current liabilities, respectively. We concluded that the failure to timely identify such accounting errors constituted a material weakness as defined in the SEC regulations. As such, management determined that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective as of March 31, 2024.

To respond to this material weakness, we have devoted, and plan to continue to devote, significant effort and resources to the remediation and improvement of our internal control over financial reporting. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to enhance our system of evaluating and implementing the complex accounting standards that apply to our financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects, or that any additional material weaknesses or of financial results will not arise in the future due to a failure to implement and maintain adequate internal control over financial reporting or circumvention of these controls. Even if we are successful in strengthening our controls and procedures, in the future those controls and procedures may not be adequate to prevent or identify irregularities or errors or to facilitate the fair presentation of our financial statements.

Changes in Internal Control Over Financial Reporting

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

The Company is not party to any legal proceedings as of the filing date of this Form 10-Q.

ITEM 1A. RISK FACTORS.

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our annual report on the Form 10K for the fiscal year ended December 31, 2023 under Forward-Looking Statements and Item 1A – Risk Factors, filed with the SEC. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Simultaneously with the closing of the Company’s IPO, the Company consummated the private placement (“Private Placement”) with its sponsor, A-Star Management Corp., a British Virgin Islands company (“Sponsor”) for the purchase of 330,000 Units (the “Private Units”) at a price of $10.00 per Private Unit, generating total proceeds of $3,300,000, pursuant to the Private Placement Unit Purchase Agreement dated December 13, 2021. Each Private Unit purchased by the Sponsor consists of one Shares, one right to receive one-seventh 1/7) of a Share upon the consummation of a business combination and one private placement warrant exercisable to purchase one-half (1/2) of one Share at a price of $10.00 per Share. The Private Units were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, as the transactions did not involve a public offering.

Use of Proceeds

The registration statement for our initial public offering was declared effective by the Securities and Exchange Commission on December 13, 2021. We completed our initial public offering on December 15, 2021. In our initial public offering, we sold units at an offering price of $10.00 and consisting of one ordinary share, one right and one redeemable warrant. Each right entitles the holders thereof to receive one seventh (1/7) of one ordinary shares upon the consumption of the initial business combination. Each warrant entitles the holder thereof to purchase one-half of one ordinary share. We will not issue fractional shares in connection with the exercise of the warrants. In connection with our initial public offering, we sold 11,500,000 units, generating gross proceeds of $115,000,000.

Simultaneously with the closing of the IPO, pursuant to the Private Placement Units Purchase Agreement by and between the Company and our sponsor, A-Star Management Corporation, the Company completed the private sale of an aggregate of 330,000 units (the “Private Placement Units”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $3,300,000.

Transaction costs related to our IPO amounted to $5,669,696, consisting of $2,300,000 of underwriting fees, $2,875,000 of deferred underwriting fees and $494,696 of other offering costs. A total of $115,000,000, comprised of $112,700,000 of the proceeds from the IPO (which amount includes up to $2,875,000 of the underwriter’s deferred discount) and $2,300,000 of the proceeds of the sale of the Private Placement Units, was placed in a U.S.-based Trust Account maintained at Wilmington Trust, National Association, acting as trustee. Except with respect to interest earned on the funds in the Trust Account that may be released to the Company to pay its taxes, the funds held in the Trust Account will not be released from the Trust Account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of any of the Company’s public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it does not complete its initial business combination within 9 months from the closing of the IPO (or up to 21 months from the closing of the IPO if we extend the period of time to consummate a business combination), or (B) with respect to any other provision relating to shareholders’ rights or pre-business combination activity, and (iii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 9 months from the closing of the IPO (or up to 27 months from the consummation of the IPO if we extend the period of time to consummate a business combination). At the Annual General Meeting held on July 13, 2023, shareholders approved the amendments of the Company’s Amended and Restated Memorandum and Articles of Association to extend the date by which the Company must consummate a business combination to March 15, 2024. At the Extraordinary General Meeting held on January 10, 2024, shareholders approved the amendments of the Company’s Amended and Restated Memorandum and Articles of Association extend the date by which the Company must consummate a business combination to September 15, 2024 (33 months from the consummation of the IPO). At the Annual General Meeting held on July 12, 2024, shareholders approved the amendments of the Company’s Amended and Restated Memorandum and Articles of Association to extend the date by which the Company must consummate a business combination to December 15, 2024.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

ITEM 6. EXHIBITS.

The following exhibits are filed as part of, or incorporated by reference into, this Amendment.

No.		Description of Exhibit
31.1		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS		Inline XBRL Instance Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.

SIGNATURES

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ALPHA STAR ACQUISITION CORPORATION

Date: July 30, 2024		/s/ Zhe Zhang
	Name:	Zhe Zhang
	Title:	Chief Executive Officer (Principle Executive Officer)

Date: July 30, 2024		/s/ Guojian Chen
	Name:	Guojian Chen
	Title:	Chief Financial Officer (Principle Financial Officer)

Exhibit 31.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302

I, Zhe Zhang, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Alpha Star Acquisition Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: July 30, 2024	By:	/s/ Zhe Zhang
		Zhe Zhang
		Chief Executive Officer and Chairman
		(Principal Executive Officer)

Exhibit 31.2

CERTIFICATIONS OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302

I, Guojian Chen, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Alpha Star Acquisition Corporation;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: July 30, 2024	By:	/s/ Guojian Chen
		Guojian Chen Chief Financial Officer
		(Principal Financial and Accounting Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Alpha Star Acquisition Corporation (the “Company”) on Form 10-Q for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Date: July 30, 2024	By:	/s/ Zhe Zhang
		Zhe Zhang
		Chief Executive Officer and Chairman
		(Principal Executive Officer)

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Date: July 30, 2024

By:

/s/ Guojian Chen

Guojian Chen

Chief Financial Officer

(Principal Financial and Accounting Officer)

Cover - $ / shares	3 Months Ended
Cover - $ / shares	Mar. 31, 2024	Jul. 12, 2024
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	001-41153
Entity Registrant Name	ALPHA STAR ACQUISITION CORPORATION
Entity Central Index Key	0001865111
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	80 Broad Street
Entity Address, Address Line Two	5th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10004
City Area Code	(212)
Local Phone Number	837-7977
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		8,948,580
Entity Listing, Par Value Per Share	$ 0.001
Units, each Consisting of One Ordinary Share, One Redeemable Warrant and One Warrant [Member]
Title of 12(b) Security	Units, each consisting of one ordinary share, one redeemable warrant, and one right
Trading Symbol	ALSAU
Security Exchange Name	NASDAQ
Ordinary Shares, $0.001 Par Value [Member]
Title of 12(b) Security	Ordinary Shares, $0.001 par value
Trading Symbol	ALSA
Security Exchange Name	NASDAQ
Redeemable Warrants, Entitle the Holder to Purchase One-half (1/2) of One Ordinary Share [Member]
Title of 12(b) Security	Redeemable warrants entitle the holder to purchase one-half (1/2) of one ordinary share
Trading Symbol	ALSAW
Security Exchange Name	NASDAQ
Rights, Entitle the Holder to Receive One-Seventh (1/7) of one Ordinary Share [Member]
Title of 12(b) Security	Rights entitle the holders to receive one-seventh (1/7) of one Ordinary Share
Trading Symbol	ALSAR
Security Exchange Name	NASDAQ

Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Prepaid expense	$ 66,375	$ 12,500
Total current assets	66,375	12,500
Noncurrent assets:
Marketable securities held in trust account	65,650,502	101,590,662
Total noncurrent assets	65,650,502	101,590,662
Total assets	65,716,877	101,603,162
Current liabilities:
Accrued expenses	323,728	220,401
Promissory note – Sponsor	6,035,961	5,755,961
Total current liabilities	6,761,830	6,189,022
Noncurrent liabilities:
Deferred underwriting commissions	2,875,000	2,875,000
Total noncurrent liabilities	2,875,000	2,875,000
Total liabilities	9,636,830	9,064,022
Commitment and contingencies (Note 6)
Ordinary shares subject to possible redemption, 5,743,580 and 9,063,503 shares at redemption value of $11.42 and $11.21 per share at March 31, 2024 and December 31, 2023, respectively	65,595,501	101,605,662
Stockholders’ deficit:
Ordinary shares, par value $0.001, authorized 50,000,000 shares; 3,205,000 and 3,205,000 shares issued and outstanding at March 31 2024 and December 31, 2023, respectively, excluding 5,743,580 and 9,063,503 shares subject to possible redemption	3,205	3,205
Additional paid-in capital
Accumulated deficit	(9,518,659)	(9,069,727)
Total stockholders’ deficit	(9,515,454)	(9,066,522)
Total liabilities and stockholders’ deficit	65,716,877	101,603,162
Related Party [Member]
Current liabilities:
Due to related parties	$ 402,141	$ 212,660

Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Odinary shares subject to possible redemption	5,743,580	9,063,503
Ordinary shares subject to possible redemption, per share	$ 11.42	$ 11.21
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	3,205,000	3,205,000
Common stock, shares outstanding	3,205,000	3,205,000

Statements of Operations (Unaudited) - USD ($)	3 Months Ended
Statements of Operations (Unaudited) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Formation and operational costs	$ 238,932	$ 121,309
Loss from operations	(238,932)	(121,309)
Other income:
Interest realized on marketable securities held in Trust Account	677,001	807,326
Unrealized gain on marketable securities held in Trust Account	285,976	461,067
Total other income	962,977	1,268,393
Income before income taxes	724,045	1,147,084
Income tax expense
Net income	$ 724,045	$ 1,147,084
Redeemable Shares [Member]
Other income:
Basic weighted average shares outstanding	6,108,407	11,500,000
Diluted weighted average shares outstanding	6,108,407	11,500,000
Basic net income (loss) per share	$ 0.14	$ 0.12
Diluted net income (loss) per share	$ 0.14	$ 0.12
Nonredeemable Shares [Member]
Other income:
Basic weighted average shares outstanding	3,205,000	3,205,000
Diluted weighted average shares outstanding	3,205,000	3,205,000
Basic net income (loss) per share	$ (0.05)	$ (0.09)
Diluted net income (loss) per share	$ (0.05)	$ (0.09)

Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022	$ 3,205	$ (4,522,095)	$ (4,518,890)
Balance, shares at Dec. 31, 2022	3,205,000
Subsequent measurement of ordinary shares subject to possible redemption (interest earned and unrealized gain on trust account)		(1,268,393)	(1,268,393)
Subsequent measurement of ordinary shares subject to possible redemption (additional funding for business combination extension)		(1,149,999)	(1,149,999)
Net income		1,147,084	1,147,084
Balance at Mar. 31, 2023	$ 3,205	(5,793,403)	(5,790,198)
Balance, shares at Mar. 31, 2023	3,205,000
Balance at Dec. 31, 2023	$ 3,205	(9,069,727)	(9,066,522)
Balance, shares at Dec. 31, 2023	3,205,000
Subsequent measurement of ordinary shares subject to possible redemption (interest earned and unrealized gain on trust account)		(962,977)	(962,977)
Subsequent measurement of ordinary shares subject to possible redemption (additional funding for business combination extension)		(210,000)	(210,000)
Net income		724,045	724,045
Balance at Mar. 31, 2024	$ 3,205	$ (9,518,659)	$ (9,515,454)
Balance, shares at Mar. 31, 2024	3,205,000

Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ 724,045	$ 1,147,084
Net changes in operating assets & liabilities:
Prepaid expenses	(53,875)	(52,500)
Interest earned in Trust Account	(962,977)	(1,268,393)
Due to related parties	189,481	140,977
Accrued expenses	103,326	(58,965)
Net cash used in operating activities		(91,797)
Cash flows from investing activities:
Investment of cash in Trust Account	(280,000)	(1,149,999)
Cash withdrawn from Trust Account to redeem public shares	37,183,138
Cash withdrawn from Trust Account for account service fee		7,500
Net cash provided by (used in) investing activities	36,903,138	(1,142,499)
Cash flows from financing activities:
Proceeds from Sponsor loan	280,000	1,149,999
Redemption of Public Shares	(37,183,138)
Net cash (used in) provided by financing activities	(36,903,138)	1,149,999
Net decrease in cash in escrow		(84,297)
Cash in escrow at beginning of period		110,991
Cash in escrow at end of period		26,694
Supplemental disclosure of non-cash investing and financing activities:
Subsequent measurement of ordinary shares subject to possible redemption	$ 1,172,977	$ 2,418,392

Description of Organization and Business Operations

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Description of Organization and Business Operations

Note 1 – Description of Organization and Business Operations

Organization and General

Extraordinary General Meeting

Extension fees

The Trust Account

Liquidity and Going Concern

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

Emerging Growth Company

Use of Estimates

Cash in Escrow

Concentration of Credit Risk

Marketable Securities Held in Trust Account

In January and February, 2024, the total amounts of $37,183,138 was withdrawn from the Trust account for the redemption of 3,319,923 public shares.

Ordinary Shares Subject to Possible Redemption

Offering Costs Associated with the Initial Public Offering

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheets, primarily due to the short-term nature.

Net Income (Loss) per Share

The net income (loss) per share presented in the statements of operations is based on the following:

Schedule of Statement of Operations

	For the Three Months Ended March 31, 2024			For the Three Months Ended March 31, 2023
Net income	$	724,045		$	1,147,084
Remeasurement to redemption value – interest income earned		(962,977	)		(1,268,393	)
Remeasurement to redemption value – extension fee		(210,000	)		(1,149,999	)
Net loss including accretion of temporary equity to redemption value	$	(448,932	)	$	(1,271,308	)

Schedule of Net Income (Loss) Per Share


	For the Three Months Ended March 31, 2024						For the Three Months Ended March 31, 2023
	Non-redeemable shares			Redeemable shares			Non-redeemable shares			Redeemable shares
Basic and Diluted net income (loss) per share:
Numerators:
Allocation of net losses	$	(154,490	)	$	(294,442	)	$	(277,085	)	$	(994,223	)
Accretion of extension fee		-			210,000			-			1,149,999
Accretion of temporary equity - interest income earned		-			962,977			-			1,268,393
Allocation of net income (loss)	$	(154,490	)	$	878,535		$	(277,085	)	$	1,424,169

Denominators:
Weighted-average shares outstanding		3,205,000			6,108,407			3,205,000			11,500,000
Basic and diluted net income (loss) per share	$	(0.05	)	$	0.14		$	(0.09	)	$	0.12

Income Taxes

The provision for income taxes was deemed to be immaterial for the three months ended March 31, 2024 and for the three months ended March 31, 2023.

Warrants

Recently Issued Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

3 Months Ended

Mar. 31, 2024

Regulated Operations [Abstract]

Initial Public Offering

Note 3 – Initial Public Offering

Private Placement

3 Months Ended

Mar. 31, 2024

Private Placement

Private Placement

Note 4 – Private Placement

Related Party Transactions

3 Months Ended

Mar. 31, 2024

Related Party Transactions

Note 5 – Related Party Transactions

Founder Shares

On April 6, 2021, the Sponsor purchased 2,875,000 ordinary shares for an aggregate price of $25,000.

Administrative Services Agreement

Promissory Note — Sponsor

The Company had issued the following promissory notes (collectively, the “Notes”):

The total balance of the Notes was $6,035,961 and $5,755,961 as of March 31, 2024 and December 31, 2023, respectively, which was for the purpose of paying extension contribution.

Due to related parties

Commitments and Contingencies

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 6 – Commitments and Contingencies

Risks and Uncertainties

Underwriters Agreement

On December 15, 2021, the Company paid a cash underwriting commission of 2.0% of the gross proceeds of the IPO, or $2,300,000.

Registration Rights

Contingencies and Dismissal of the Then-Legal Counsel

Stockholders’ Deficit

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Stockholders’ Deficit

Note 7 – Stockholders’ Deficit

Ordinary Shares

Public Warrants

Private warrants

Rights

Fair Value Measurements

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurements

Note 8 – Fair Value Measurements

The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

At March 31, 2024 and December 31, 2023, assets held in the Trust Account were entirely comprised of marketable securities.

As of March 31, 2024		Quoted Prices in Active Markets (Level 1)				Significant Other Observable Inputs (Level 2)				Significant Other Unobservable Inputs (Level 3)
Marketable Securities held in Trust Account		$	65,650,502			$	-			$	-

As of December 31, 2023		Quoted Prices in Active Markets (Level 1)				Significant Other Observable Inputs (Level 2)				Significant Other Unobservable Inputs (Level 3)
Marketable Securities held in Trust Account		$	101,590,662			$	-			$	-

Subsequent Events

3 Months Ended

Mar. 31, 2024

Subsequent Events [Abstract]

Subsequent Events

Note 9 – Subsequent Events

Sponsor payment on behalf of the Company

Enter into Letter of Intent

Annual General Meeting

Drawdown of Promissory Notes

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Emerging Growth Company

Emerging Growth Company

Use of Estimates

Use of Estimates

Cash in Escrow

Cash in Escrow

Concentration of Credit Risk

Concentration of Credit Risk

Marketable Securities Held in Trust Account

Marketable Securities Held in Trust Account

In January and February, 2024, the total amounts of $37,183,138 was withdrawn from the Trust account for the redemption of 3,319,923 public shares.

Ordinary Shares Subject to Possible Redemption

Ordinary Shares Subject to Possible Redemption

Offering Costs Associated with the Initial Public Offering

Offering Costs Associated with the Initial Public Offering

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheets, primarily due to the short-term nature.

Net Income (Loss) per Share

Net Income (Loss) per Share

The net income (loss) per share presented in the statements of operations is based on the following:

Schedule of Statement of Operations

	For the Three Months Ended March 31, 2024			For the Three Months Ended March 31, 2023
Net income	$	724,045		$	1,147,084
Remeasurement to redemption value – interest income earned		(962,977	)		(1,268,393	)
Remeasurement to redemption value – extension fee		(210,000	)		(1,149,999	)
Net loss including accretion of temporary equity to redemption value	$	(448,932	)	$	(1,271,308	)

Schedule of Net Income (Loss) Per Share


	For the Three Months Ended March 31, 2024						For the Three Months Ended March 31, 2023
	Non-redeemable shares			Redeemable shares			Non-redeemable shares			Redeemable shares
Basic and Diluted net income (loss) per share:
Numerators:
Allocation of net losses	$	(154,490	)	$	(294,442	)	$	(277,085	)	$	(994,223	)
Accretion of extension fee		-			210,000			-			1,149,999
Accretion of temporary equity - interest income earned		-			962,977			-			1,268,393
Allocation of net income (loss)	$	(154,490	)	$	878,535		$	(277,085	)	$	1,424,169

Denominators:
Weighted-average shares outstanding		3,205,000			6,108,407			3,205,000			11,500,000
Basic and diluted net income (loss) per share	$	(0.05	)	$	0.14		$	(0.09	)	$	0.12

Income Taxes

Income Taxes

The provision for income taxes was deemed to be immaterial for the three months ended March 31, 2024 and for the three months ended March 31, 2023.

Warrants

Warrants

Recently Issued Accounting Standards

Recently Issued Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Schedule of Statement of Operations

The net income (loss) per share presented in the statements of operations is based on the following:

Schedule of Statement of Operations

	For the Three Months Ended March 31, 2024			For the Three Months Ended March 31, 2023
Net income	$	724,045		$	1,147,084
Remeasurement to redemption value – interest income earned		(962,977	)		(1,268,393	)
Remeasurement to redemption value – extension fee		(210,000	)		(1,149,999	)
Net loss including accretion of temporary equity to redemption value	$	(448,932	)	$	(1,271,308	)

Schedule of Net Income (Loss) Per Share


	For the Three Months Ended March 31, 2024						For the Three Months Ended March 31, 2023
	Non-redeemable shares			Redeemable shares			Non-redeemable shares			Redeemable shares
Basic and Diluted net income (loss) per share:
Numerators:
Allocation of net losses	$	(154,490	)	$	(294,442	)	$	(277,085	)	$	(994,223	)
Accretion of extension fee		-			210,000			-			1,149,999
Accretion of temporary equity - interest income earned		-			962,977			-			1,268,393
Allocation of net income (loss)	$	(154,490	)	$	878,535		$	(277,085	)	$	1,424,169

Denominators:
Weighted-average shares outstanding		3,205,000			6,108,407			3,205,000			11,500,000
Basic and diluted net income (loss) per share	$	(0.05	)	$	0.14		$	(0.09	)	$	0.12

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Fair Value Hierarchy of Valuation Inputs

As of March 31, 2024		Quoted Prices in Active Markets (Level 1)				Significant Other Observable Inputs (Level 2)				Significant Other Unobservable Inputs (Level 3)
Marketable Securities held in Trust Account		$	65,650,502			$	-			$	-

As of December 31, 2023		Quoted Prices in Active Markets (Level 1)				Significant Other Observable Inputs (Level 2)				Significant Other Unobservable Inputs (Level 3)
Marketable Securities held in Trust Account		$	101,590,662			$	-			$	-

Description of Organization and Business Operations (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended	10 Months Ended
	Dec. 15, 2021	Jul. 31, 2023	Mar. 31, 2024	Jun. 30, 2023	Jan. 31, 2024	Jan. 10, 2024	Dec. 31, 2023	Sep. 20, 2023	Jul. 13, 2023	Mar. 13, 2023	Dec. 31, 2022	Dec. 13, 2022	Sep. 13, 2022
Subsidiary, Sale of Stock [Line Items]
Sale of units per share			$ 12.50
Sale of stock, consideration received on transaction	$ 115,000,000
Redemption public shares						3,319,923			2,436,497
Redemption amount									$ 26,094,883
Redemption of public shares						3,319,923
Redemption of public shares amount						$ 37,183,138
Amount deposited in trust account				$ 383,333
Payments for Other Fees		$ 302,116		$ 383,333
Shares Issued, Price Per Share				$ 0.033
Share Price		$ 0.033			$ 0.033
Notes Payable					$ 70,000
Net proceeds from the IPO	115,682,250
Escrow cash transfered	$ 682,250
Cash in escrow			$ 0				$ 0
Working capital deficit			6,710,455				6,191,522
Marketable securities			15,000				$ 15,000
Related party loans			$ 1,500,000
First Note [Member] \| Sponsor [Member]
Subsidiary, Sale of Stock [Line Items]
Principal amount													$ 1,000,000
Second Note [Member] \| Sponsor [Member]
Subsidiary, Sale of Stock [Line Items]
Principal amount											$ 1,300,000	$ 1,300,000
Third Note [Member] \| Sponsor [Member]
Subsidiary, Sale of Stock [Line Items]
Principal amount										$ 2,500,000
Fourth Note [Member] \| Sponsor [Member]
Subsidiary, Sale of Stock [Line Items]
Principal amount								$ 2,500,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering	11,500,000		11,500,000
Sale of units per share	$ 10.00
Sale of stock, consideration received on transaction	$ 115,000,000
Net proceeds from the IPO	$ 2,300,000		$ 2,875,000
Over-Allotment Option [Member] \| Underwriters [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering	1,500,000
Share Price	$ 10.00
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering	330,000
Sale of units per share	$ 10.00
Sale of stock, consideration received on transaction	$ 3,300,000

Schedule of Statement of Operations (Details) - USD ($)	3 Months Ended
Schedule of Statement of Operations (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Accounting Policies [Abstract]
Net income	$ 724,045	$ 1,147,084
Remeasurement to redemption value – interest income earned	(962,977)	(1,268,393)
Remeasurement to redemption value – extension fee	(210,000)	(1,149,999)
Net loss including accretion of temporary equity to redemption value	$ (448,932)	$ (1,271,308)

Schedule of Net Income (Loss) Per Share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Nonredeemable Shares [Member]
Allocation of net losses	$ (154,490)	$ (277,085)
Accretion of extension fee
Accretion of temporary equity - interest income earned
Allocation of net income (loss)	$ (154,490)	$ (277,085)
Weighted-average shares outstanding - Basic	3,205,000	3,205,000
Weighted-average shares outstanding - Diluted	3,205,000	3,205,000
Diluted net income (loss) per share Basic	$ (0.05)	$ (0.09)
Diluted net income (loss) per share Diluted	$ (0.05)	$ (0.09)
Redeemable Shares [Member]
Allocation of net losses	$ (294,442)	$ (994,223)
Accretion of extension fee	210,000	1,149,999
Accretion of temporary equity - interest income earned	962,977	1,268,393
Allocation of net income (loss)	$ 878,535	$ 1,424,169
Weighted-average shares outstanding - Basic	6,108,407	11,500,000
Weighted-average shares outstanding - Diluted	6,108,407	11,500,000
Diluted net income (loss) per share Basic	$ 0.14	$ 0.12
Diluted net income (loss) per share Diluted	$ 0.14	$ 0.12

Summary of Significant Accounting Policies (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended
	Dec. 15, 2021	Feb. 29, 2024	Jan. 31, 2024	Mar. 31, 2024	Mar. 31, 2023	Jan. 10, 2024	Dec. 31, 2023	Jul. 13, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Cash in escrow				$ 0			$ 0
Cash, FDIC insured amount				250,000
Assets held in trust				65,650,502			$ 101,590,662
Interest income other				962,977	$ 1,268,393
Interest income reinvested in trust account				677,001	807,326
Unrealized gain on investments				$ 285,976	$ 461,067
Odinary shares subject to possible redemption				5,743,580			9,063,503
Interest to pay dissolution expenses				$ 50,000
Warrants exercisable to purchase of ordinary shares				1,690,000
Rights exercisable to convert of ordinary shares				5,915,000
Redemption public shares						3,319,923		2,436,497
IPO [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of units in initial public offering	11,500,000			11,500,000
Odinary shares subject to possible redemption				11,500,000
Wilming Ton [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Assets held in trust		$ 37,183,138	$ 37,183,138
Public shares		3,319,923	3,319,923

Initial Public Offering (Details Narrative) - USD ($)		3 Months Ended
Initial Public Offering (Details Narrative) - USD ($)	Dec. 15, 2021	Mar. 31, 2024
Subsidiary, Sale of Stock [Line Items]
Sale of units per share		$ 12.50
Sale of units in initial public offering aggregate amount	$ 115,000,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering	11,500,000	11,500,000
Sale of units per share	$ 10.00
Sale of units in initial public offering aggregate amount	$ 115,000,000
Over-Allotment Option [Member] \| Underwriters [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering	1,500,000

Private Placement (Details Narrative) - USD ($)	Dec. 15, 2021	Mar. 31, 2024
Subsidiary, Sale of Stock [Line Items]
Sale of units per share		$ 12.50
Sale of units in initial public offering aggregate amount	$ 115,000,000
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering	330,000
Sale of units per share	$ 10.00
Sale of units in initial public offering aggregate amount	$ 3,300,000

Related Party Transactions (Details Narrative) - USD ($)				3 Months Ended
	Dec. 13, 2021	Apr. 06, 2021	Mar. 11, 2021	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Sep. 20, 2023	Mar. 13, 2023	Dec. 31, 2022	Dec. 13, 2022	Sep. 13, 2022
Related Party Transaction [Line Items]
Sale of Stock, Price Per Share				$ 12.50
Administrative Fees Expense				$ 30,000	$ 30,000
Lender description				Up to $1,500,000 of such loans may be convertible into units at a price of $10.00 per unit (which, for example, would result in the holders being issued 150,000 ordinary shares, 150,000 rights and 150,000 warrants to purchase 75,000 shares if $1,500,000 of notes were so converted) at the option of the lender. The units would be identical to the placement units issued to the initial holder
Promissory note balances				$ 6,035,961		$ 5,755,961
First Note [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Principal amount											$ 1,000,000
Second Note [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Principal amount									$ 1,300,000	$ 1,300,000
Third Note [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Principal amount								$ 2,500,000
Fourth Note [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Principal amount							$ 2,500,000
Founder [Member]
Related Party Transaction [Line Items]
Number of shares issued, shares			2,875,000
Stock repurchased and retired during period, shares			375,000
Sponsor [Member]
Related Party Transaction [Line Items]
Number of shares forfeited		2,875,000
Value of shares forfeited		$ 25,000
[custom:RelatedPartyServiceFee]	$ 10,000
Convertible loans
Related Party [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Due to related party				$ 402,141		$ 212,660

Commitments and Contingencies (Details Narrative) - USD ($)			3 Months Ended
	Feb. 05, 2024	Dec. 15, 2021	Mar. 31, 2024	Jan. 31, 2024	Dec. 31, 2023	Jul. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Share price				$ 0.033		$ 0.033
Gross proceeds from Initial Public Offering		$ 115,682,250
Deferred underwriting commission			$ 2,875,000		$ 2,875,000
Sponsor [Member]
Defined Benefit Plan Disclosure [Line Items]
Value of stock issued for services	$ 200,000
IPO [Member]
Defined Benefit Plan Disclosure [Line Items]
Sale of units in initial public offering		11,500,000	11,500,000
Percentage of cash underwritng commission		2.00%
Gross proceeds from Initial Public Offering		$ 2,300,000	$ 2,875,000
Percentage of deferred underwriting commission			2.50%
Underwriters [Member] \| Over-Allotment Option [Member]
Defined Benefit Plan Disclosure [Line Items]
Sale of units in initial public offering		1,500,000
Sale of units		10,000,000
Share price		$ 10.00

Stockholders’ Deficit (Details Narrative) - USD ($)		3 Months Ended
Stockholders’ Deficit (Details Narrative) - USD ($)	Dec. 15, 2021	Mar. 31, 2024	Jan. 31, 2024	Dec. 31, 2023	Jul. 31, 2023	Jun. 30, 2023
Class of Warrant or Right [Line Items]
Common stock, shares authorized		50,000,000		50,000,000
Common stock par value		$ 0.001		$ 0.001
Common stock, shares issued		3,205,000		3,205,000
Common stock, shares outstanding		3,205,000		3,205,000
Temporary Equity, Shares Authorized		5,743,580		9,063,503
Sale of stock, price per share		$ 12.50
Proceeds from sale of stock	$ 115,000,000
Share Price			$ 0.033		$ 0.033
Shares price per share						$ 0.033
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Sale of units in initial public offering		11,500,000
Sale of stock, price per share		$ 10.00
Proceeds from sale of stock		$ 115,000,000
Share Price		$ 11.50
Warrants outstanding		11,500,000		11,500,000
Class of warrants or rights redemption price per share		$ 0.01
Shares price per share		$ 18.00
Number of consecutive trading days for determining the volume weighted average price of share		20 days
Class of warrants or rights period within the registration shall be effective from the consummation of business combination		60 days
Volume weighted average price per share		$ 9.20
Percentage of funds raised to be used for consummating business combination		60.00%
Class of warrants or rights exercise price percentage		115.00%
Class of warrants or rights exercise price percentage		180.00%
Private Warrants [Member]
Class of Warrant or Right [Line Items]
Warrants outstanding		330,000		330,000

Schedule of Fair Value Hierarchy of Valuation Inputs (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities held in Trust Account	$ 15,000	$ 15,000
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities held in Trust Account	65,650,502	101,590,662
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities held in Trust Account
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities held in Trust Account

Subsequent Events (Details Narrative) - USD ($)		1 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Jul. 12, 2024	Jul. 26, 2024	Jul. 28, 2024	Jan. 31, 2024	Jun. 30, 2023
Subsequent Event [Line Items]
Shares issued price per share					$ 0.033
Notes payable				$ 70,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Stock issued during period shares new issues	4,840,581
Shares issued price per share	$ 11.61
Extension fees	$ 35,000
Drew down amount			$ 210,000
Subsequent Event [Member] \| May Twenty Twenty Four To June Twenty Twenty Four [Member]
Subsequent Event [Line Items]
Notes payable			70,000
Subsequent Event [Member] \| July Twenty Twenty Four To August Twenty Twenty Four [Member]
Subsequent Event [Line Items]
Notes payable			$ 35,000
Subsequent Event [Member] \| Sponsor [Member]
Subsequent Event [Line Items]
Operating expenses		$ 250,713
Due to sponsor		$ 652,854

Alpha Star Acquisition (NASDAQ:ALSAU)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024

Haga Click aquí para más Gráficas Alpha Star Acquisition.

Alpha Star Acquisition (NASDAQ:ALSAU)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

ALSAU Alpha Star Acquisition Corporation

Noticias sobre Alpha Star Acquisition Corporation ALSAU

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Tendencias Ahora

Listas Principales

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

ALSAU Alpha Star Acquisition Corporation

Noticias sobre Alpha Star Acquisition Corporation ALSAU

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación